Palisade Bio Files Definitive Proxy Statement

TL;DR

Palisade Bio proxy statement out - shareholders vote on directors & auditors.

AI Summary

Palisade Bio, Inc. filed its definitive proxy statement on May 22, 2024, for its annual meeting of stockholders. The filing details the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of the independent registered public accounting firm.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership and proposals, enabling them to make informed voting decisions at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new material financial or operational information.

Key Players & Entities

• PALISADE BIO, INC. (company) — Registrant
• 0001493152-24-021034 (filing_id) — Accession Number
• 20240522 (date) — Filing Date

FAQ

Filing Documents

• formdef14a.htm (DEF 14A) — 856KB
• def14a_001.jpg (GRAPHIC) — 4KB
• def14a_003.jpg (GRAPHIC) — 28KB
• def14a_004.jpg (GRAPHIC) — 27KB
• proxycard_001.jpg (GRAPHIC) — 740KB
• proxycard_002.jpg (GRAPHIC) — 303KB
• 0001493152-24-021034.txt ( ) — 2375KB

From the Filing

DEF 14A 1 formdef14a.htm UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy (Amendment No.__) Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under § 240.14a-12 PALISADE BIO, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box ): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 PALISADE BIO, INC. 7750 El Camino Real, Suite 2A Carlsbad, California 92009 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held on July 8, 2024 Dear Stockholder: You are cordially invited to attend the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of Palisade Bio, Inc., a Delaware corporation (the “Company”), to be held on the 8th day of July, 2024, at 10:00 a.m. Pacific Time. The Annual Meeting will be held in a virtual meeting format only, via live webcast on the Internet, with no physical in-person meeting. You will be able to attend and participate in the Annual Meeting online by visiting www.proxydocs.com/PALI , where you will be able to listen to the meeting live, submit questions and vote. You will need to register at www.proxydocs.com/PALI in order to attend the Annual Meeting virtually. You will need to have the 12-digit control number which is included in the Notice of Internet Availability of Proxy Materials (“Notice”), on your proxy card or on the instructions that accompanied your proxy materials to join the virtual Annual Meeting. You will not be able to attend the meeting in person. As always, we encourage you to vote your shares prior to the Annual Meeting. We are holding the Annual Meeting for the following purposes, which are more fully described in the accompanying proxy statement (“Proxy Statement”): 1. To elect three directors to hold office until the 2025 Annual Meeting of Stockholders or until a successor is duly elected and qualified or until the director’s earlier death, resignation or removal. We refer to this proposal as the “Director Election Proposal” or “Proposal 1.” 2. To ratify the appointment of Baker Tilly US, LLP, as our independent registered public accounting firm for the fiscal year ending December 31, 2024. We refer to this proposal as the “Auditor Ratification Proposal” or “Proposal 2.” 3. To conduct any other business properly brought before the Annual Meeting. We have elected to provide electronic access to our Annual Meeting proxy materials, which include the Proxy Statement accompanying this notice, in lieu of mailing printed copies. On or about May 25, 2024, we expect to mail to our stockholders the Notice containing instructions on how to access our Proxy Statement and our Annual Report for the fiscal year ended December 31, 2023 (the “2023 Annual Report”). The Notice provides instructions on how to vote online or by telephone and how to receive a paper copy of the proxy materials by mail. Our Proxy Statement and 2023 Annual Report can be accessed directly at the Internet address www.proxydocs.com/PALI using the control number located on your Notice, and also on your proxy card or voting instruction form, as applicable, if you have received printed proxy materials. The record date for the Annual Meeting is May 16, 2024. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. You will not be able to attend the Annual Meeting in person. By Order of the Board of Directors /s/ Donald Williams Donald Williams Chairman May 22, 2024 You are cordially invited to virtually attend the Annual Meeting online. Whether or not you expect to virtually attend the Annual Meeting, PLEASE VOTE YOUR SHARES. As an alternative to voting online, you may vote via telephone or, if you receive a paper proxy card by mailing the completed proxy card. Voting instructions are provided in the instructions printed on your proxy card. Even if you have voted by proxy, you may still vote online at the Annual Meeting. Please note, however, that if your shares are held of record by a broker, bank or other agent and you wish to vote at the Annual Meeting, you must follow the instructions from such organization and will need to obtain a proxy issued in your name from that record holder. PALISADE BIO, INC. 7750 El Camino Real, Suite 2A Carlsbad, California 92009 PROXY FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HOLD ON JULY 8, 2024 Our Board of

View Full Filing

View this DEF 14A filing on SEC EDGAR